Our Blog

Cochlear (ASX:COH) receive FDA approval for the Baha sound processor

24 Feb 2021 – Hearing solutions company Cochlear (ASX:COH) has received US Food and Drug Administration (FDA) clearance and CE Mark accreditation for the new Cochlear Baha 6 Max Sound Processor.


Source: Finance News Network

Share this post